Form 4: H.B. Fuller Executive VP and CFO, John J. Corkrean, Reports Changes in Beneficial Ownership
SEC Form 4 Filing
John J. Corkrean, Executive VP and CFO of H.B. Fuller, filed a Form 4 detailing changes in his beneficial ownership of the company's securities, including the acquisition of phantom units and adjustments to holdings of employee stock options and restricted stock units.
Summary
- On March 17, 2025, John J. Corkrean, Executive VP and CFO of H.B. Fuller, reported changes in his beneficial ownership of the company's securities.
- The report details the acquisition of 176.41 phantom units on March 14, 2025, at a price of $53.43.
- Corkrean directly owns 52,196 shares of common stock.
- He also holds various employee stock options with exercise prices ranging from $43.48 to $77.72 and expiration dates between 2026 and 2035.
- Additionally, he possesses restricted stock units that convert into common stock on a 1-for-1 basis, vesting in three annual installments.
- The report includes adjustments to holdings due to dividend equivalent reinvestment features for both stock units and restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine regulatory filing, so the sentiment is neutral. It simply reflects changes in beneficial ownership.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the trading activities of company insiders. Investors monitor these filings to gain insights into management's perspective on the company's stock and future prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are common across publicly traded companies.
- The vesting schedules and exercise prices of H.B. Fuller's stock options appear to be within typical ranges for companies of its size and industry.
- Comparing the total equity holdings of John J. Corkrean to those of CFOs at similar companies (e.g., RPM International, Sherwin-Williams) could provide a benchmark for assessing his alignment with shareholder interests.
Stakeholder Impact
- The filing provides transparency to shareholders regarding the executive's stake in the company.
- It can influence investor sentiment depending on the nature and size of the transactions.
Key Dates
| Date | Description |
|---|---|
| 05/17/2017 | Date of exercisability for some employee stock options. |
| 01/26/2018 | Date of exercisability for some employee stock options. |
| 01/25/2019 | Date of exercisability for some employee stock options. |
| 01/24/2020 | Date of exercisability for some employee stock options. |
| 01/24/2021 | Date of exercisability for some employee stock options. |
| 01/27/2022 | Date of exercisability for some employee stock options. |
| 01/24/2023 | Date of exercisability for some employee stock options. |
| 01/24/2024 | Date of grant and vesting start date for some restricted stock units and employee stock options. |
| 01/26/2025 | Date of grant and vesting start date for some restricted stock units and employee stock options. |
| 03/14/2025 | Date of the transaction involving phantom units. |
| 03/17/2025 | Date of the Form 4 filing. |
| 01/26/2034 | Expiration date for some employee stock options. |
| 01/27/2035 | Expiration date for some employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.